Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

Aging impairs long-term hematopoietic regeneration after autologous stem cell transplantation.

Woolthuis CM, Mariani N, Verkaik-Schakel RN, Brouwers-Vos AZ, Schuringa JJ, Vellenga E, de Wolf JT, Huls G.

Biol Blood Marrow Transplant. 2014 Jun;20(6):865-71. doi: 10.1016/j.bbmt.2014.03.001. Epub 2014 Mar 7.

2.

Loss of quiescence and impaired function of CD34(+)/CD38(low) cells one year following autologous stem cell transplantation.

Woolthuis CM, Brouwers-Vos AZ, Huls G, de Wolf JT, Schuringa JJ, Vellenga E.

Haematologica. 2013 Dec;98(12):1964-71. doi: 10.3324/haematol.2013.086744. Epub 2013 Sep 13.

3.

Treatment with lenalidomide in myelodysplastic syndromes with deletion 5q: results from the Dutch named patient program.

Abouyahya I, Alhan C, Westers TM, te Boekhorst PA, Kappers-Klunne MC, Coenen JL, Heyning FH, Huls GA, de Wolf JT, Imholz AL, Koene HR, Veth G, de Kruijf EJ, Muus P, Planken EV, Segeren CM, Vasmel WL, van der Velden AM, Velders GA, Koedam J, Ossenkoppele GJ, van de Loosdrecht AA.

Leuk Lymphoma. 2013 Apr;54(4):874-7. doi: 10.3109/10428194.2012.728702. Epub 2012 Sep 28. No abstract available.

PMID:
22971215
4.

In vivo hemostatic efficacy of polyurethane foam compared to collagen and gelatin.

Broekema FI, van Oeveren W, Selten MH, Meijer RJ, de Wolf JT, Bos RR.

Clin Oral Investig. 2013 May;17(4):1273-8. doi: 10.1007/s00784-012-0809-y. Epub 2012 Aug 2.

PMID:
22855267
5.

F-18 FLT PET: a noninvasive diagnostic tool for visualization of the bone marrow compartment in patients with aplastic anemia: a pilot study.

Agool A, Slart RH, Kluin PM, de Wolf JT, Dierckx RA, Vellenga E.

Clin Nucl Med. 2011 Apr;36(4):286-9. doi: 10.1097/RLU.0b013e31820aa1a1.

PMID:
21368602
6.

An assessment of clinical interchangeability of TEG and RoTEM thromboelastographic variables in cardiac surgical patients.

Venema LF, Post WJ, Hendriks HG, Huet RC, de Wolf JT, de Vries AJ.

Anesth Analg. 2010 Aug;111(2):339-44. doi: 10.1213/ANE.0b013e3181e368bc. Epub 2010 Jun 7.

PMID:
20529981
7.

Extramedullary haematopoiesis imaging with 18F-FLT PET.

Agool A, Dierckx RA, de Wolf JT, Vellenga E, Slart RH.

Eur J Nucl Med Mol Imaging. 2010 Aug;37(8):1620. doi: 10.1007/s00259-010-1486-1. Epub 2010 May 29. No abstract available.

8.

Transfused stored platelets have the same haemostatic function as circulating native platelets.

Roeloffzen WW, Kluin-Nelemans HC, Veeger NJ, Bosman L, de Wolf JT.

Vox Sang. 2010 Aug 1;99(2):123-30. doi: 10.1111/j.1423-0410.2010.01337.x. Epub 2010 Apr 23.

PMID:
20456723
9.

Thrombocytopenia affects plasmatic coagulation as measured by thrombelastography.

Roeloffzen WW, Kluin-Nelemans HC, Mulder AB, de Wolf JT.

Blood Coagul Fibrinolysis. 2010 Jul;21(5):389-97. doi: 10.1097/MBC.0b013e328335d0e4.

PMID:
20410815
10.

In normal controls, both age and gender affect coagulability as measured by thrombelastography.

Roeloffzen WW, Kluin-Nelemans HC, Mulder AB, Veeger NJ, Bosman L, de Wolf JT.

Anesth Analg. 2010 Apr 1;110(4):987-94. doi: 10.1213/ANE.0b013e3181d31e91.

PMID:
20357143
11.

Efficacy of single-agent lenalidomide in patients with JAK2 (V617F) mutated refractory anemia with ring sideroblasts and thrombocytosis.

Huls G, Mulder AB, Rosati S, van de Loosdrecht AA, Vellenga E, de Wolf JT.

Blood. 2010 Jul 15;116(2):180-2. doi: 10.1182/blood-2010-01-263087. Epub 2010 Mar 1.

PMID:
20194893
12.

Effects of red blood cells on hemostasis.

Roeloffzen WW, Kluin-Nelemans HC, Bosman L, de Wolf JT.

Transfusion. 2010 Jul;50(7):1536-44. doi: 10.1111/j.1537-2995.2010.02586.x. Epub 2010 Feb 11.

PMID:
20158685
13.

Quantifying the reduction in immunoglobulin use over time in patients with chronic immune thrombocytopenic purpura receiving romiplostim (AMG 531).

Pullarkat VA, Gernsheimer TB, Wasser JS, Newland A, Guthrie TH Jr, de Wolf JT, Stewart R, Berger D.

Am J Hematol. 2009 Aug;84(8):538-40. doi: 10.1002/ajh.21463. No abstract available.

14.

Erythroid precursors from patients with low-risk myelodysplasia demonstrate ultrastructural features of enhanced autophagy of mitochondria.

Houwerzijl EJ, Pol HW, Blom NR, van der Want JJ, de Wolf JT, Vellenga E.

Leukemia. 2009 May;23(5):886-91. doi: 10.1038/leu.2008.389. Epub 2009 Jan 15.

PMID:
19148135
15.

Platelet production rate predicts the response to prednisone therapy in patients with idiopathic thrombocytopenic purpura.

Houwerzijl EJ, Louwes H, Sluiter WJ, Smit JW, Vellenga E, de Wolf JT.

Ann Hematol. 2008 Dec;87(12):975-83. doi: 10.1007/s00277-008-0537-1. Epub 2008 Aug 9.

PMID:
18690441
16.

Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial.

Kuter DJ, Bussel JB, Lyons RM, Pullarkat V, Gernsheimer TB, Senecal FM, Aledort LM, George JN, Kessler CM, Sanz MA, Liebman HA, Slovick FT, de Wolf JT, Bourgeois E, Guthrie TH Jr, Newland A, Wasser JS, Hamburg SI, Grande C, Lefrère F, Lichtin AE, Tarantino MD, Terebelo HR, Viallard JF, Cuevas FJ, Go RS, Henry DH, Redner RL, Rice L, Schipperus MR, Guo DM, Nichol JL.

Lancet. 2008 Feb 2;371(9610):395-403. doi: 10.1016/S0140-6736(08)60203-2.

PMID:
18242413
17.

A 'pre-induction course' with non-cross-reacting cytostatic drugs for rapid tumour load reduction improves outcome in adult acute lymphoblastic leukaemia.

Daenen S, van Imhoff GW, de Wolf JT, Vellenga E, van den Berg-de Ruiter E, Kluin-Nelemans HC.

Br J Haematol. 2007 Jul;138(2):275-7. No abstract available.

PMID:
17593034
18.

Megakaryocytic dysfunction in myelodysplastic syndromes and idiopathic thrombocytopenic purpura is in part due to different forms of cell death.

Houwerzijl EJ, Blom NR, van der Want JJ, Vellenga E, de Wolf JT.

Leukemia. 2006 Nov;20(11):1937-42. Epub 2006 Sep 7. Review.

PMID:
16990774
19.

Thromboelastographic evaluation of recombinant factor VIIa in a child with Glanzmann's thrombasthenia.

Ismael F, van der Meer J, de Wolf JT, Kuizenga K, Aarts LP, Hendriks HG.

Anesth Analg. 2006 Sep;103(3):791-2. No abstract available.

PMID:
16931713
20.

Cost-effectiveness of pathogen inactivation for platelet transfusions in the Netherlands.

Postma MJ, van Hulst M, De Wolf JT, Botteman M, Staginnus U.

Transfus Med. 2005 Oct;15(5):379-87.

PMID:
16202052
21.

Splenectomy for the treatment of thrombotic thrombocytopenic purpura.

Kappers-Klunne MC, Wijermans P, Fijnheer R, Croockewit AJ, van der Holt B, de Wolf JT, Löwenberg B, Brand A.

Br J Haematol. 2005 Sep;130(5):768-76. Review.

PMID:
16115135
22.
23.

Intraoperative blood transfusion requirement is the main determinant of early surgical re-intervention after orthotopic liver transplantation.

Hendriks HG, van der Meer J, de Wolf JT, Peeters PM, Porte RJ, de Jong K, Lip H, Post WJ, Slooff MJ.

Transpl Int. 2005 Jan;17(11):673-9. Epub 2004 Dec 10.

PMID:
15717214
24.

Adjusted transfusion triggers improve transfusion practice in orthopaedic surgery.

Eindhoven GB, Diercks RL, Richardson FJ, van Raaij JJ, Hagenaars JA, van Horn JR, de Wolf JT.

Transfus Med. 2005 Feb;15(1):13-8.

PMID:
15713124
25.

Combined thalidomide and cyclophosphamide treatment for refractory or relapsed multiple myeloma patients: a prospective phase II study.

Hovenga S, Daenen SM, de Wolf JT, van Imhoff GW, Kluin-Nelemans HC, Sluiter WJ, Vellenga E.

Ann Hematol. 2005 May;84(5):311-6. Epub 2004 Dec 17.

PMID:
15605244
26.

Increased peripheral platelet destruction and caspase-3-independent programmed cell death of bone marrow megakaryocytes in myelodysplastic patients.

Houwerzijl EJ, Blom NR, van der Want JJ, Louwes H, Esselink MT, Smit JW, Vellenga E, de Wolf JT.

Blood. 2005 May 1;105(9):3472-9. Epub 2004 Nov 12.

PMID:
15542580
27.

Limited numbers of apoptotic cells in fresh paraffin embedded bone marrow samples of patients with myelodysplastic syndrome.

Brada SJ, van de Loosdrecht AA, Koudstaal J, de Wolf JT, Vellenga E.

Leuk Res. 2004 Sep;28(9):921-5.

PMID:
15234568
28.

Factors influencing haematological recovery following high-dose chemotherapy and peripheral stem-cell transplantation for haematological malignancies; 1-year analysis.

Nieboer P, de Vries EG, Vellenga E, van der Graaf WT, Mulder NH, Sluiter WJ, de Wolf JT.

Eur J Cancer. 2004 May;40(8):1199-207.

PMID:
15110884
29.

Ultrastructural study shows morphologic features of apoptosis and para-apoptosis in megakaryocytes from patients with idiopathic thrombocytopenic purpura.

Houwerzijl EJ, Blom NR, van der Want JJ, Esselink MT, Koornstra JJ, Smit JW, Louwes H, Vellenga E, de Wolf JT.

Blood. 2004 Jan 15;103(2):500-6. Epub 2003 Sep 11.

PMID:
12969975
30.

Recombinant factor VIIa in orthotopic liver transplantation: influence on parameters of coagulation and fibrinolysis.

Meijer K, Hendriks HG, De Wolf JT, Klompmaker IJ, Lisman T, Hagenaars AA, Slooff MJ, Porte RJ, van der Meer J.

Blood Coagul Fibrinolysis. 2003 Feb;14(2):169-74.

PMID:
12632027
31.

Pharmaco-economics of blood transfusion safety: review of the available evidence.

van Hulst M, de Wolf JT, Staginnus U, Ruitenberg EJ, Postma MJ.

Vox Sang. 2002 Aug;83(2):146-55. Review.

PMID:
12201844
32.

Effects of recombinant activated factor VII on coagulation measured by thromboelastography in liver transplantation.

Hendriks HG, Meijer K, de Wolf JT, Porte RJ, Klompmaker IJ, Lip H, Slooff MJ, van der Meer J.

Blood Coagul Fibrinolysis. 2002 Jun;13(4):309-13.

PMID:
12032396
33.

Evaluation assays measuring platelet kinetics in bone marrow and peripheral blood. An overview.

Louwes H, De Wolf JT, Houwerzijl E, Vellenga E.

Nucl Med Commun. 2002 Jun;23(6):581-90. Review.

PMID:
12029215
34.

In vitro megakaryocyte expansion in patients with delayed platelet engraftment after autologous stem cell transplantation.

Drayer AL, Smit Sibinga CT, Esselink MT, de Wolf JT, Vellenga E.

Ann Hematol. 2002 Apr;81(4):192-7. Epub 2002 Mar 22.

PMID:
11976820
35.

Effects of prednisone and splenectomy in patients with idiopathic thrombocytopenic purpura: only splenectomy induces a complete remission.

Louwes H, Vellenga E, Houwerzijl EJ, de Wolf JT.

Ann Hematol. 2001 Dec;80(12):728-32. Epub 2001 Oct 24.

PMID:
11797113
36.
37.

Partial tetrasomy of 9P: a rare chromosomal abnormality in polycythaemia vera.

van de Loosdrecht AA, de Wolf JT, Noordhoek L, van den Berg E.

Br J Haematol. 2001 Mar;112(4):1086-7. No abstract available.

PMID:
11324639
38.

Mitochondrial disruption and limited apoptosis of erythroblasts are associated with high risk myelodysplasia. An ultrastructural analysis.

van de Loosdrecht AA, Brada SJ, Blom NR, Hendriks DW, Smit JW, van den Berg E, de Wolf JT, Vellenga E.

Leuk Res. 2001 May;25(5):385-93.

PMID:
11301106
39.

Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation: a pilot study.

Hendriks HG, Meijer K, de Wolf JT, Klompmaker IJ, Porte RJ, de Kam PJ, Hagenaars AJ, Melsen T, Slooff MJ, van der Meer J.

Transplantation. 2001 Feb 15;71(3):402-5.

PMID:
11233901
40.

6-Mercaptopurine, Still Valuable for the Palliative Treatment of Acute Myeloid Leukaemia.

Daenen SM, De Wolf JT, Vellenga E, Van Imhoff GW, Smit JW, Berg-De Rutter EV.

Hematology. 2001;6(4):231-40. doi: 10.1080/10245332.2001.11746576.

PMID:
27414842
41.

The in vitro effects of cytokines on expansion and migration of megakaryocyte progenitors.

Drayer AL, Sibinga CT, Blom NR, De Wolf JT, Vellenga E.

Br J Haematol. 2000 Jun;109(4):776-84.

PMID:
10929029
42.

Blood loss in orthotopic liver transplantation: a retrospective analysis of transfusion requirements and the effects of autotransfusion of cell saver blood in 164 consecutive patients.

Hendriks HG, van der Meer J, Klompmaker IJ, Choudhury N, Hagenaars JA, Porte RJ, de Kam PJ, Slooff MJ, de Wolf JT.

Blood Coagul Fibrinolysis. 2000 Apr;11 Suppl 1:S87-93.

PMID:
10850571
43.

Autologous stem cell transplantation in multiple myeloma after VAD and EDAP courses: a high incidence of oligoclonal serum Igs post transplantation.

Hovenga S, de Wolf JT, Guikema JE, Klip H, Smit JW, Smit Sibinga CT, Bos NA, Vellenga E.

Bone Marrow Transplant. 2000 Apr;25(7):723-8.

44.

Excessive apoptosis of bone marrow erythroblasts in a patient with autoimmune haemolytic anaemia with reticulocytopenia.

Van De Loosdrecht AA, Hendriks DW, Blom NR, Smit JW, De Wolf JT, Vellenga E.

Br J Haematol. 2000 Feb;108(2):313-5.

PMID:
10691861
45.

Platelet kinetic studies in patients with idiopathic thrombocytopenic purpura.

Louwes H, Zeinali Lathori OA, Vellenga E, de Wolf JT.

Am J Med. 1999 Apr;106(4):430-4.

PMID:
10225246
46.

Effective treatment of severe bleeding due to acquired thrombocytopathia by single dose administration of activated recombinant factor VII.

Meijer K, Sieders E, Slooff MJ, de Wolf JT, van der Meer J.

Thromb Haemost. 1998 Jul;80(1):204-5. No abstract available.

PMID:
9684815
47.
48.
49.

Supplemental Content

Loading ...
Support Center